CTI BIOPHARMA CORP (24) | Uncategorized (6)
Recent Contracts
-
Description of Securities
(Filed With SEC on March 31, 2022)
-
Offer Letter, by and between CTI BioPharma Corp. and James K. Fong, dated as of March 1, 2022
(Filed With SEC on March 4, 2022)
-
Description of Securities
(Filed With SEC on March 17, 2021)
-
Open Market Sale AgreementSM, dated as of January 15, 2021, by and between CTI BioPharma Corp. and Jefferies LLC
(Filed With SEC on January 15, 2021)
-
Description of Securities
(Filed With SEC on March 13, 2020)
-
Open Market Sale AgreementSM, dated as of November 15, 2019, between CTI BioPharma Corp. and Jefferies LLC
(Filed With SEC on November 15, 2019)
